Predicting drug metabolism - An evaluation of the expert system METEOR

Chemistry and Biodiversity

Volumn 2, Issue 7, 2005, Pages 872-885

  Testa, Bernard ^a,c   Balmat, Anne Loyse ^a   Long, Anthony ^b   Judson, Philip ^b  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; DICLOFENAC; DRUG METABOLITE; ESONARIMOD; ETOPERIDONE; GALANTAMINE; GEMIFLOXACIN; HEXANE; INDINAVIR; OMAPATRILAT; TRAMADOL; XENOBIOTIC AGENT;

ACCURACY; ARTICLE; COMPARATIVE MOLECULAR FIELD ANALYSIS; COMPUTER MODEL; COMPUTER PROGRAM; DRUG HYDROLYSIS; DRUG METABOLISM; DRUG OXIDATION; DRUG STRUCTURE; EXPERT SYSTEM; HUMAN; IN VIVO STUDY; NONHUMAN; PREDICTION; SENSITIVITY AND SPECIFICITY; STRUCTURE ANALYSIS; XENOBIOTIC METABOLISM;

ANALGESICS, OPIOID; CARDIOVASCULAR AGENTS; COMPUTER SIMULATION; EXPERT SYSTEMS; GALANTAMINE; HIV PROTEASE INHIBITORS; HUMANS; INDINAVIR; MOLECULAR STRUCTURE; PARASYMPATHOMIMETICS; PYRIDINES; SOFTWARE; THIAZEPINES; TRAMADOL;

EID: 23044488827     PISSN: 16121872     EISSN: 16121880     Source Type: Journal    
DOI: 10.1002/cbdv.200590064     Document Type: Article

References (66)

1. 'Pharmacokinetic Optimization in Drug Research: Biological, Physicochemical, and Computational Strategies', Eds. B. Testa, H. van de Waterbeemd, G. Folkers, R. Guy, Verlag Helvetica Chimica Acta, Zürich, Wiley-VCH, Weinheim, 2001.
2. B. Testa, W. Soine, in 'Burger's Medicinal Chemistry and Drug Discovery', 6th edn., Ed. D. J. Abraham, Wiley-Interscience, Hoboken, 2003, Vol. 2, p. 431-498.
3. B. Testa, 'The Metabolism of Drugs and Other Xenobiotics-Biochemistry of Redox Reactions', Academic Press, London, 1995.
4. B. Testa, J. M. Mayer, 'Hydrolysis in Drug and Prodrug Metabolism - Chemistry, Biochemistry, and Enzymology', Verlag Helvetica Chimica, Acta, Zürich, Wiley-VCH, Weinheim, 2003.
5. a) A. J. Henderson, P. R. Guzzo, Curr. Drug Discov. 2004, May, 17.
6. b) J. E. Penzotti, G. A. Landrum, S. Putta, Curr. Opin. Drug Discov. Dev. 2004, 7, 49.
7. c) A. G. E. Wilson, A. C. White, R. A. Mueller, Curr. Opin. Drug Discov. Dev. 2003, 6, 123.
8. d) H. van de Waterbeemd, E. Gifford, Nature Rev. Drug Discov. 2003, 2, 192.
9. e) D. P. Williams, D. J. Naisbitt, Curr. Opin. Drug Discov. Dev. 2002, 5, 104.
10. f) H. van de Waterbeemd, Curr. Opin. Drug Discov. Dev. 2002, 5, 33.
11. g) A. P. Li, Drug Des. Technol. 2001, 6, 357.
12. h) T. N. Thompson, Med. Res. Rev. 2001, 21, 412.
13. i) D. A. Smith, B. C. Jones, D. K. Walker, Med. Res. Rev. 1996, 16, 243.
14. B. Testa, A. L. Balmat, A. Long, Pure Appl. Chem. 2004, 76, 907.
15. C. Hansch, S. B. Mekapati, A. Kurup, R. P. Verma, Drug Metab. Rev. 2004, 36, 105.
16. B. Testa, P. Crivori, M. Reist, P. A. Carrupt, Perspect. Drug Discov. Des. 2000, 19, 179.
17. D. F. V. Lewis, Drug Metab. Rev. 1997, 29, 589.
18. D. Korolev, K. V. Balakin, Y. Nikolsky, E. Kirillov, Y. A. Ivanenkov, N. P. Savchuk, A. A. Ivashchenko, T. Nikolskaya, J. Med. Chem. 2003, 46, 3631.
19. D. L. Harris, Curr. Opin. Drug Discov. Dev. 2004, 7, 43.
20. J. P. Jones, M. Mysinger, K. R. Korzekwa, Drug Metab. Disposit. 2002, 30, 7.
21. R. N. Hines, Z. Luo, T. Cresteil, X. Ding, R. A. Prough, J. L. Fitzpatrick, S. L. Ripp, K. C. Falkner, N. L. Ge, A. Levine, C. J. Elferink, Drug Metab. Disposit. 2001, 29, 623.
22. M. D. Segall, M. C. Payne, S. W. Ellis, G. T. Tucker, P. J. Eddershaw, Xenobiotica 1999, 29, 561.
23. D. F. V. Lewis, Drug Metab. Rev. 1999, 31, 755.
24. P. A. Smith, M. J. Sorich, R. A. McKinnon, J. O. Miners, J. Med. Chem. 2003, 46, 1617.
25. S. Ekins, D. M. Stresser, J. A. Williams, Trends Pharmacol. Sci. 2003, 24, 161.
26. A. Poso, J. Gynther, R. Juvonen, J. Comput.-Aided Mol. Des. 2001, 15, 195.
27. S. Ekins, R. S. Obach, J. Pharmacol. Exp. Ther. 2000, 295, 463.
28. S. Ekins, G. Bravi, J. H. Wikel, S. A. Wrighton, J. Pharmacol. Exp. Ther. 1999, 291, 424.
29. L. Afzelius, I. Zamora, C. M. Masimirembwa, A. Karlén, T. B. Andersson, S. Mecussi, M. Baroni, G. Cruciani, J. Med. Chem. 2004, 47, 907.
30. I. Zamora, L. Afzelius, G. Cruciani, J. Med. Chem. 2003, 46, 2313.
31. M. J. Sorich, J. O. Miners, R. A. McKinnon, P. A. Smith, Mol. Pharmacol. 2004, 65, 301.
32. J. Venhorst, A. M. ter Laak, J. N. M. Commandeur, Y. Funae, T. Hiroi, N. P. E. Vermeulen, J. Med. Chem. 2003, 43, 74.
33. D. F. V. Lewis, Xenobiotica 2002, 32, 305.
34. D. F. V. Lewis, Drug Metab. Rev. 2002, 34, 55.
35. A. M. ter Laak, N. P. E. Vermeulen, in 'Pharmacokinetic Optimization in Drug Research - Biological, Physicochemical and Computational Strategies', Eds. B. Testa, H. van de Waterbeemd, G. Folkers, R. Guy, Verlag Helvetica Chimica Acta, Zurich, Wiley-VCH, Weinheim, 2001, p. 551-588.
36. D. F. V. Lewis, B. G. Lake, Xenobiotica 1999, 29, 763.
37. S. Chen, K. Wu, D. Zhang, M. Sherman, R. Know, C. S. Yang, Mol. Pharmacol. 1999, 56, 272.
38. M. J. de Groot, N. P. E. Vermeulen, Drug Metab. Rev. 1997, 29, 747.
39. P. A. Williams, J. Cosme, D. M. Vinkovic, A. Ward, H. C. Angove, P. J. Day, C. Vonrhein, I. J. Tickle, H. Jhoti, Science 2004, 305, 683.
40. P. A. Williams, J. Cosme, A. Ward, H. C. Angove, D. M. Vinkovic, H. Jhoti, Nature 2003, 424, 464.
41. P. A. Williams, J. Cosme, V. Sridhar, E. F. Johnson, D. E. McRee, Mol. Cell 2000, 5, 121.
42. G. Cruciani, R. Vianello, I. Zamora, in 'Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies', Eds. B. Testa, S. Kraemer, H. Wunderli-Allenspach, G. Folkers, Verlag Helvetica Chimica Acta, Zurich, Wiley-VCH, Weinheim, 2005, in press.
43. M. J. de Groot, A. A. Alex, B. C. Jones, J. Med. Chem. 2002, 45, 1983;
44. c) M. J. de Groot, M. J. Ackland, V. A. Horne, A. A. Alex, B. C. Jones, J. Med. Chem. 1999, 42, 4062.
45. M. J. de Groot, M. J. Ackland, V. A. Horne, A. A. Alex, B. C. Jones, J. Med. Chem. 1999, 42, 1515.
46. D. R. Hawkins, Drug Discov. Today 1999, 4, 466.
47. 'Metabolism Databases and High-Throughput Testing During Drug Design and Development', Ed. P. W. Erhardt, Blackwell Science, London, 1999.
48. http://www.mdl.com
49. 'Biotransformations: A Survey of the Biotransformations of Drugs and Chemicals in Animals', Ed. D. R. Hawkins, The Royal Society of Chemistry, London, Vol. 1-7, 1988-1996.
50. http://www.accelrys.com
51. http://www.compudrug.com
52. http://www.multicase.com
53. http://www.lhasalimited.org
54. a) P. N. Judson, in 'Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies', Eds. B. Testa, S. Kraemer, H. Wunderli-Allenspach, G. Folkers, Verlag Helvetica Chimica Acta, Zurich, Wiley-VCH, Weinheim, 2005, in press.
55. b) P. N. Judson, J. D. Vessey, J. Chem. Inf. Comput. Sci. 2003, 43, 1356.
56. c) P. N. Judson, C. A. Marchant, J. D. Vessey, J. Chem. Inf. Comput. Sci. 2003, 43, 1364.
57. d) W. G. Button, P. N. Judson, A. Long, J. D. Vessey, J. Chem. Inf. Comput. Sci. 2003, 43, 1371.
58. e) J. J. Langowski, A. Long, Adv. Drug Deliv. Rev. 2002, 54, 407.
59. f) C. A. G. Tonnelier, J. Fox, P. N. Judson, P. J. Krause, N. Pappas, M. Patel, J. Chem. Inf. Comput. Sci. 1997, 37, 117.
60. g) P. N. Judson, J. Fox, P. J. Krause, J. Chem. Inf. Comput. Sci. 1996, 36, 621.
61. http://www.daylight.com
62. G. S. J. Mannens, C. A. W. Snel, I Hendrickx, T. Verhaeghe, L. Le Jenne, W. Bode, L. Van Beijsterveldt, K. Lavrijsen, J. Leempoels, N. Van Osselaer, A. Van Peer, W. Meuldermans, Drug Metab. Disp. 2002, 30, 553.
63. W. N. Wu, L. A. McKown, S. Liao, Xenobiotica 2002, 32, 411.
64. R. A. Iyer, B. Malhotra, S. Khan, J. Mitroka, S. Bonacorsi Jr., S. C. Waller, J. K. Rinehart, K. Kripalani, Drug Metab. Disp. 2003, 31, 67.
65. S. K. Balani, B. H. Arison, L. Mathai, L. R. Kauffman, R. R. Miller, R. A. Stearns, I. W. Chen, J. H. Lin, Drug Metab. Disp. 1995, 23, 266.
66. J. H. Lin, Adv. Drug Deliv. Rev. 1999, 39, 33.